Chromosomal Imbalances in Patients with Congenital Cardiac Defects: A Meta‐analysis Reveals Novel Potential Critical Regions Involved in Heart Development
dc.contributor.author | Thorsson, Thor | en_US |
dc.contributor.author | Russell, William W. | en_US |
dc.contributor.author | El‐kashlan, Nour | en_US |
dc.contributor.author | Soemedi, Rachel | en_US |
dc.contributor.author | Levine, Jonathan | en_US |
dc.contributor.author | Geisler, Sarah B. | en_US |
dc.contributor.author | Ackley, Todd | en_US |
dc.contributor.author | Tomita‐mitchell, Aoy | en_US |
dc.contributor.author | Rosenfeld, Jill A. | en_US |
dc.contributor.author | Töpf, Ana | en_US |
dc.contributor.author | Tayeh, Marwan | en_US |
dc.contributor.author | Goodship, Judith | en_US |
dc.contributor.author | Innis, Jeffrey W. | en_US |
dc.contributor.author | Keavney, Bernard | en_US |
dc.contributor.author | Russell, Mark W. | en_US |
dc.date.accessioned | 2015-07-01T20:56:11Z | |
dc.date.available | 2016-07-05T17:27:58Z | en |
dc.date.issued | 2015-05 | en_US |
dc.identifier.citation | Thorsson, Thor; Russell, William W.; El‐kashlan, Nour ; Soemedi, Rachel; Levine, Jonathan; Geisler, Sarah B.; Ackley, Todd; Tomita‐mitchell, Aoy ; Rosenfeld, Jill A.; Töpf, Ana ; Tayeh, Marwan; Goodship, Judith; Innis, Jeffrey W.; Keavney, Bernard; Russell, Mark W. (2015). "Chromosomal Imbalances in Patients with Congenital Cardiac Defects: A Metaâ analysis Reveals Novel Potential Critical Regions Involved in Heart Development." Congenital Heart Disease (3): 193-208. | en_US |
dc.identifier.issn | 1747-079X | en_US |
dc.identifier.issn | 1747-0803 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/111936 | |
dc.description.abstract | ObjectiveCongenital cardiac defects represent the most common group of birth defects, affecting an estimated six per 1000 births. Genetic characterization of patients and families with cardiac defects has identified a number of genes required for heart development. Yet, despite the rapid pace of these advances, mutations affecting known genes still account for only a small fraction of congenital heart defects suggesting that many more genes and developmental mechanisms remain to be identified.DesignIn this study, we reviewed 1694 described cases of patients with cardiac defects who were determined to have a significant chromosomal imbalance (a deletion or duplication). The cases were collected from publicly available databases (DECIPHER, ISCA, and CHDWiki) and from recent publications. An additional 68 nonredundant cases were included from the University of Michigan. Cases with multiple chromosomal or whole chromosome defects (trisomy 13, 18, 21) were excluded, and cases with overlapping deletions and/or insertions were grouped to identify regions potentially involved in heart development.ResultsSeventy‐nine chromosomal regions were identified in which 5 or more patients had overlapping imbalances. Regions of overlap were used to determine minimal critical domains most likely to contain genes or regulatory elements involved in heart development. This approach was used to refine the critical regions responsible for cardiac defects associated with chromosomal imbalances involving 1q24.2, 2q31.1, 15q26.3, and 22q11.2.ConclusionsThe pattern of chromosomal imbalances in patients with congenital cardiac defects suggests that many loci may be involved in normal heart development, some with very strong and direct effects and others with less direct effects. Chromosomal duplication/deletion mapping will provide an important roadmap for genome‐wide sequencing and genetic mapping strategies to identify novel genes critical for heart development. | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Congenital Heart Defects | en_US |
dc.subject.other | Heart Development | en_US |
dc.subject.other | Chromosomal Imbalance | en_US |
dc.title | Chromosomal Imbalances in Patients with Congenital Cardiac Defects: A Meta‐analysis Reveals Novel Potential Critical Regions Involved in Heart Development | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/111936/1/chd12179.pdf | |
dc.identifier.doi | 10.1111/chd.12179 | en_US |
dc.identifier.source | Congenital Heart Disease | en_US |
dc.identifier.citedreference | Adeyinka A, Stockero KJ, Flynn HC, Lorentz CP, Ketterling RP, Jalal SM. Familial 22q11.2 deletions in DiGeorge/velocardiofacial syndrome are predominantly smaller than the commonly observed 3Mb. Genet Med. 2004; 6: 517 – 520. | en_US |
dc.identifier.citedreference | Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005; 437: 270 – 274. | en_US |
dc.identifier.citedreference | Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci U S A. 1999; 96: 23 – 28. | en_US |
dc.identifier.citedreference | van Loo PF, Mahtab EA, Wisse LJ, et al. Transcription factor Sp3 knockout mice display serious cardiac malformations. Mol Cell Biol. 2007; 27: 8571 – 8582. | en_US |
dc.identifier.citedreference | Subramanian SV, Nadal‐Ginard B. Early expression of the different isoforms of the myocyte enhancer factor‐2 (MEF2) protein in myogenic as well as non‐myogenic cell lineages during mouse embryogenesis. Mech Dev. 1996; 57: 103 – 112. | en_US |
dc.identifier.citedreference | Yagi H, Furutani Y, Hamada H, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003; 362: 1366 – 1373. | en_US |
dc.identifier.citedreference | Lindsay EA, Vitelli F, Su H, et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature. 2001; 410: 97 – 101. | en_US |
dc.identifier.citedreference | Merscher S, Funke B, Epstein JA, et al. TBX1 is responsible for cardiovascular defects in velo‐cardio‐facial/DiGeorge syndrome. Cell. 2001; 104: 619 – 629. | en_US |
dc.identifier.citedreference | Jerome LA, Papaioannou VE. DiGeorge syndrome phenotype in mice mutant for the T‐box gene, Tbx1. Nat Genet. 2001; 27: 286 – 291. | en_US |
dc.identifier.citedreference | Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol. 2010; 105: 1617 – 1624. | en_US |
dc.identifier.citedreference | Breckpot J, Thienpont B, Bauters M, et al. Congenital heart defects in a novel recurrent 22q11.2 deletion harboring the genes CRKL and MAPK1. Am J Med Genet A. 2012; 158A: 574 – 580. | en_US |
dc.identifier.citedreference | Shaikh TH, Kurahashi H, Saitta SC, et al. Chromosome 22‐specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet. 2000; 9: 489 – 501. | en_US |
dc.identifier.citedreference | Saitta SC, Harris SE, Gaeth AP, et al. Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. Hum Mol Genet. 2004; 13: 417 – 428. | en_US |
dc.identifier.citedreference | Morrow B, Goldberg R, Carlson C, et al. Molecular definition of the 22q11 deletions in velo‐cardio‐facial syndrome. Am J Hum Genet. 1995; 56: 1391 – 1403. | en_US |
dc.identifier.citedreference | Rauch A, Zink S, Zweier C, et al. Systematic assessment of atypical deletions reveals genotype‐phenotype correlation in 22q11.2. J Med Genet. 2005; 42: 871 – 876. | en_US |
dc.identifier.citedreference | Guris DL, Duester G, Papaioannou VE, Imamoto A. Dose‐dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev Cell. 2006; 10: 81 – 92. | en_US |
dc.identifier.citedreference | Burkardt DD, Rosenfeld JA, Helgeson ML, et al. Distinctive phenotype in 9 patients with deletion of chromosome 1q24‐q25. Am J Med Genet A. 2011; 155A: 1336 – 1351. | en_US |
dc.identifier.citedreference | Hennies HC, Kornak U, Zhang H, et al. Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab‐6 interacting golgin. Nat Genet. 2008; 40: 1410 – 1412. | en_US |
dc.identifier.citedreference | Sergi C, Kamnasaran D. PRRX1 is mutated in a fetus with agnathia‐otocephaly. Clin Genet. 2011; 79: 293 – 295. | en_US |
dc.identifier.citedreference | Martin JF, Bradley A, Olson EN. The paired‐like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev. 1995; 9: 1237 – 1249. | en_US |
dc.identifier.citedreference | Liu J, Luo XJ, Xiong AW, et al. MicroRNA‐214 promotes myogenic differentiation by facilitating exit from mitosis via down‐regulation of proto‐oncogene N‐ras. J Biol Chem. 2010; 285: 26599 – 26607. | en_US |
dc.identifier.citedreference | Cho TJ, Kim OH, Choi IH, et al. A dominant mesomelic dysplasia associated with a 1.0‐Mb microduplication of HOXD gene cluster at 2q31.1. J Med Genet. 2010; 47: 638 – 639. | en_US |
dc.identifier.citedreference | Theisen A, Rosenfeld JA, Shane K, et al. Refinement of the region for split hand/foot malformation 5 on 2q31.1. Mol Syndromol. 2010; 1: 262 – 271. | en_US |
dc.identifier.citedreference | Gotoh I, Adachi M, Nishida E. Identification and characterization of a novel MAP kinase kinase kinase, MLTK. J Biol Chem. 2001; 276: 4276 – 4286. | en_US |
dc.identifier.citedreference | Rump P, Dijkhuizen T, Sikkema‐Raddatz B, et al. Drayer's syndrome of mental retardation, microcephaly, short stature and absent phalanges is caused by a recurrent deletion of chromosome 15(q26.2→qter). Clin Genet. 2008; 74: 455 – 462. | en_US |
dc.identifier.citedreference | Tonnies H, Schulze I, Hennies H, Neumann LM, Keitzer R, Neitzel H. De novo terminal deletion of chromosome 15q26.1 characterised by comparative genomic hybridisation and FISH with locus specific probes. J Med Genet. 2001; 38: 617 – 621. | en_US |
dc.identifier.citedreference | Morales J, Al‐Sharif L, Khalil DS, et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am J Hum Genet. 2009; 85: 558 – 568. | en_US |
dc.identifier.citedreference | Hinton RB, Martin LJ, Rame‐Gowda S, Tabangin ME, Cripe LH, Benson DW. Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. J Am Coll Cardiol. 2009; 53: 1065 – 1071. | en_US |
dc.identifier.citedreference | Vitelli F, Morishima M, Taddei I, Lindsay EA, Baldini A. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum Mol Genet. 2002; 11: 915 – 922. | en_US |
dc.identifier.citedreference | Fagerberg CR, Graakjaer J, Heinl UD, et al. Heart defects and other features of the 22q11 distal deletion syndrome. Eur J Med Genet. 2013; 56: 98 – 107. | en_US |
dc.identifier.citedreference | Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet. 2001; 27: 293 – 298. | en_US |
dc.identifier.citedreference | Ohye RG, Sleeper LA, Mahony L, et al. Comparison of shunt types in the Norwood procedure for single‐ventricle lesions. N Engl J Med. 2010; 362: 1980 – 1992. | en_US |
dc.identifier.citedreference | Petit CJ. Staged single‐ventricle palliation in 2011: outcomes and expectations. Congenit Heart Dis. 2011; 6: 406 – 416. | en_US |
dc.identifier.citedreference | Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007; 115: 3015 – 3038. | en_US |
dc.identifier.citedreference | McCulley DJ, Black BL. Transcription factor pathways and congenital heart disease. Curr Top Dev Biol. 2012; 100: 253 – 277. | en_US |
dc.identifier.citedreference | Wolf M, Basson CT. The molecular genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol. 2010; 25: 192 – 197. | en_US |
dc.identifier.citedreference | Millan MJ. An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology. 2013; 68: 2 – 82. | en_US |
dc.identifier.citedreference | Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone‐modifying genes in congenital heart disease. Nature. 2013; 498: 220 – 223. | en_US |
dc.identifier.citedreference | Ferencz C, Neill CA, Boughman JA, Rubin JD, Brenner JI, Perry LW. Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr. 1989; 114: 79 – 86. | en_US |
dc.identifier.citedreference | Firth HV, Richards SM, Bevan AP, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensemble resources. Am J Hum Genet. 2009; 84: 524 – 533. | en_US |
dc.identifier.citedreference | Barriot R, Breckpot J, Thienpont B, et al. Collaboratively charting the gene‐to‐phenotype network of human congenital heart defects. Genome Med. 2010; 2: 16. | en_US |
dc.identifier.citedreference | Greenway SC, Pereira AC, Lin JC, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet. 2009; 41: 931 – 935. | en_US |
dc.identifier.citedreference | Tomita‐Mitchell A, Mahnke DK, Struble CA, et al. Human gene copy number spectra analysis in congenital heart malformations. Physiol Genomics. 2012; 44: 518 – 541. | en_US |
dc.identifier.citedreference | Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011; 43: 838 – 846. | en_US |
dc.identifier.citedreference | Soemedi R, Wilson IJ, Bentham J, et al. Contribution of global rare copy‐number variants to the risk of sporadic congenital heart disease. Am J Hum Genet. 2012; 91: 489 – 501. | en_US |
dc.identifier.citedreference | Baldwin EL, Lee JY, Blake DM, et al. Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med. 2008; 10: 415 – 429. | en_US |
dc.identifier.citedreference | Quinonez SC, Hedera P, Barr M, et al. Maternal intrachromosomal insertional translocation leads to recurrent 1q21.3q23.3 deletion in two siblings. Am J Med Genet A. 2012; 158A: 2591 – 2601. | en_US |
dc.identifier.citedreference | Thienpont B, Zhang L, Postma AV, et al. Haploinsufficiency of TAB2 causes congenital heart defects in humans. Am J Hum Genet. 2010; 86: 839 – 849. | en_US |
dc.identifier.citedreference | Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A. 2005; 138: 307 – 313. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.